Docetaxel and Carboplatin as First-line Chemotherapy in Early Stage as Well as Advanced or Metastatic Ovarian Cancer
Status:
Completed
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
Primary objective:
To assess response rate. To record the clinical improvement in relation to stage and
histopathological grading.
Secondary objective:
To determine progression free survival. To find out overall survival. To evaluate the safety
of the study regimen.